Justin Kirkland, MS

The Effects of AG1® Supplementation on the Gut Microbiome of Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Dr. Seeds reviews a randomized controlled study on AG1 and its potential impact on the gut microbiome. The research shows short-term probiotic survival and safety but no significant changes in microbiome diversity or systemic metabolic effects. Dr. Seeds discusses what the study supports, what it doesn’t, and why careful interpretation of research matters in clinical practice. (Article Link)

1. Post-chemotherapy fatigue and neuropathy in a colorectal cancer survivor peptide safety and immune support (0:48)
2. Severe food reactivity with mast cell involvement and redox imbalance (07:50)
3. Severe pediatric JIA with MIS-C and persistent hyperinflammation (23:34)

Rethinking OCD Through a Cellular Medicine Lens

Dr. Seeds explores OCD as a circuitry and maladaptive learning issue, discussing neurotransmitter balance, oxidative stress, and mitochondrial function while highlighting a non-SSRI approach that pairs cellular support with ERP to promote lasting change.

The Truth About Ketone Esters

Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions

Dr. Seeds reviews a newly published peer-reviewed article, coauthored with his colleagues, examining how cellular medicine and peptides support orthopedic wound healing through regenerative signaling and cellular repair mechanisms. (Article Link)

1. Peptides for fertility (0:40)
2. NAD⁺ and GHK-Cu dosing considerations (10:00)
3. Peptide safety for patient with a stroke and chronic migraines (12:33)

LADA Protocol

Dr. Seeds answers a clinician question on implementing a LADA-focused approach, clarifying peptide sequencing, biomarker monitoring, and expectations around immune modulation, metabolic support, and beta-cell preservation within a cellular medicine framework.